Associated Press: Biosion Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial of BSI-082

February 6, 2026

Associated Press: Biosion Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial of BSI-082

yahoo! news: Biosion doses first patient in phase Ia/Ib BSI-082 trial for solid tumours

February 6, 2026

John Sarantopoulos, MD, associate professor, Department of Medicine, Division of Hematology and Oncology, and medical oncologist, Mays Cancer Center, was mentioned in this article.   Read More

MSN.com: Biosion doses first patient in phase Ia/Ib BSI-082 trial for solid tumours

February 6, 2026

MSN.com: Biosion doses first patient in phase Ia/Ib BSI-082 trial for solid tumours

KSAT 12: South Texas amputee hopeful after launch of breakthrough program at UT Health San Antonio

February 6, 2026

KSAT 12: South Texas amputee hopeful after launch of breakthrough program at UT Health San Antonio

KENS 5: Healthy SA — Reducing both obesity and colon cancer risk with GLP-1s

February 4, 2026

KENS 5: Healthy SA — Reducing both obesity and colon cancer risk with GLP-1s

Mirage News: Cannabis, Drug Combo Shows Alzheimer’s Prevention Promise

February 2, 2026

Mirage News: Cannabis, Drug Combo Shows Alzheimer’s Prevention Promise